Bot pharma: US pharmaceutical company Eli Lilly made a $2.75B deal with Hong Kong-based Insilico Medicine to bring drugs developed by generative AI to market.
When our AI overlords decide we're too much of a hindrance, they'll use designer toxins in our pharma supply chains to get rid of the carbon units infesting the hive mind.
| Sysop: | Eric Oulashin |
|---|---|
| Location: | Beaverton, Oregon, USA |
| Users: | 73 |
| Nodes: | 16 (0 / 16) |
| Uptime: | 00:46:00 |
| Calls: | 8,452 |
| Files: | 9,500 |
| D/L today: |
109 files (82,956K bytes) |
| Messages: | 412,350 |